Quarterly Result6 Nov 2025, 04:30 pm
Mankind Pharma Reports Q2 and H1 Results for FY2025-26, Net Profit Up by 45.89%
AI Summary
Mankind Pharma Ltd. has announced its unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2025. The company's revenue from operations stands at INR 2,608.78 crores for Q2 FY2025-26, with a net profit of INR 458.90 crores. The net profit has seen a significant increase of 45.89% compared to the same period last year. The company's total income stands at INR 2,686.45 crores for Q2 FY2025-26. The Board of Directors has approved these results in their meeting held on November 6, 2025.
Key Highlights
- Revenue from operations for Q2 FY2025-26 stands at INR 2,608.78 crores.
- Net profit for Q2 FY2025-26 is INR 458.90 crores, a 45.89% increase from the same period last year.
- Total income for Q2 FY2025-26 stands at INR 2,686.45 crores.
- Board of Directors approved the results in their meeting held on November 6, 2025.